Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value... Show more
a developer of innovative therapeutics for cancer patients
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RWIEX | 63.25 | 0.32 | +0.51% |
American Funds Capital World Gr&Inc R4 | |||
RRRCX | 21.51 | 0.02 | +0.09% |
DWS RREEF Real Estate Securities C | |||
FRCSX | 53.82 | -0.09 | -0.17% |
Franklin Small Cap Value R6 | |||
HWLIX | 40.09 | -0.09 | -0.22% |
Hotchkis & Wiley Large Cap Fdml Value I | |||
MMRFX | 11.11 | -0.06 | -0.54% |
MassMutual Select TRP Real Asset I |
A.I.dvisor tells us that ENZN and LPCN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZN and LPCN's prices will move in lockstep.
Ticker / NAME | Correlation To ENZN | 1D Price Change % | ||
---|---|---|---|---|
ENZN | 100% | -0.13% | ||
LPCN - ENZN | 24% Poorly correlated | +0.31% | ||
CLDX - ENZN | 9% Poorly correlated | -0.05% | ||
HALO - ENZN | 7% Poorly correlated | +2.09% | ||
INCY - ENZN | 4% Poorly correlated | +0.32% | ||
TECH - ENZN | 4% Poorly correlated | -1.06% | ||
More |